India poct market outlook to 2023

May 2019
India POCT Market Outlook to 2023 - By Major Devices (Blood Glucose Testing
Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and
Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management,
Cholesterol Testing Kits and Others), By End Users (Hospitals & Clinics,
Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), By
Distribution Channel (Distributors and Direct Sales), By Consumables and
Instruments and By Region

2
Table of Contents (1/2)
1. Executive Summary
1.1. Current Scenario
1.2. Future Projections
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Consolidated Research Approach
2.4. Variables (Dependent and Independent)
2.5. Correlation Matrix
2.6. Regression Matrix
2.7. Limitations and Conclusion
3. Value Chain Analysis of India POCT Market
3.1. Overview
3.2. Networking
4. Indian National Health Account Statistics
5. Market Overview and Genesis
5. 1. Market Time Line
6. India POCT Market Size- Current and Future Scenario
6.1. By Historical Revenue, FY’2013- FY’2018
6.2. By Forecasted Revenue, FY’2018- FY’2023
7. India POCT Market Segmentation- Current and Future scenario
7.1. By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits,
Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), FY’2018- FY’2023E
7.1.1. Blood Glucose Testing Kits
7.1.2. Infectious Disease Testing Kits
7.1.3. Blood Gas Electrolytes
7.1.4. Pregnancy and Fertility Testing Kits
7.1.5. Cardio metabolic Monitoring
7.1.6. Anticoagulant Management
7.1.7. Cholesterol Testing Kits
7.1.8. Others
7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), FY’2018- FY’2023E
7.3. By Consumables and Instruments, FY’2018-FY’2023E
7.4. By Distribution Channel (Distributors and Direct Sales), FY’2018
7.5. By Region (Tier 1, Tier 2 and Tier 3 Cities), FY’2018 and FY’2023E
8. Trends and Development of India POCT Market

3
Table of Contents (2/2)
9. Issues and Challenges of India POCT Market
10. Government Regulations for India POCT Market
10.1. Regulations for IVD Medical Devices
10.2. Regulatory Approval Process for Manufacture for Sale/Distribution of Medical Devices
10.3. Procedure to Apply for Import of Medical Devices
10.4. Fees and Charges for Medical Devices in India
10.5. List of Application Forms Required to Apply for Medical Devices Approval
10.6. List of Documents required with the Application for Grant of License to Manufacture or import of Medical Device
11. Trade Scenario of the India POCT Market
11.1. Import Value and Importing Countries, FY’2014-FY’2018
11.2. Export Value and Destinations of POCT Devices by India, FY’2014-FY’2018
11.3. Cross Comparison between Domestic Production and Import of POCT Devices (Major Products Manufactured in India, Major Imported
Products, Major Manufacturers in India, Initiatives for manufacturing and others), FY’2018
11.4. Manufacturing Units of major POCT Device Manufacturers in India
12. Funding and Mergers and Acquisitions Scenario in the India POCT Market
13. Customer Decision Parameters in India POCT Market
14. Porter’s Five Forces in India POCT Market
15. Competition Landscape of India POCT Market
15.1. Competitive Scenario (Competing Parameters, Major Players and Competition Structure)
15.2. Market Share of Major Players - By Revenue, FY’2018
16. Strength and Weaknesses of Major Players in India POCT Market
17. Company Profiles of Major Players in India POCT Market including (Company Overview, Business Model, Strengths, Market Share, Key
POCT Devices Offered, Total Income from All Brands, Financials, Mergers and Acquisitions and Product Profile)
17.1. Abbott India Limited
17.2. Roche Diagnostics
17.3. Siemens Healthcare Private Limited
17.4. Beckman Coulter India Pvt Ltd
17.5. J Mitra & co. Pvt. Ltd.
17.6. Trans Asia Bio Medical
17.7. Radiometer India
17.8. Bio Rad Laboratories
17.9. DiaSys India
17.10. Other Companies (EKF Diagnostics, Renesas Electronics, Triviton Healthcare Private Limited, Becton Dickinson India Private Limited
and India Medtronic Private Limited)
18. Upcoming Technologies in India POCT Market
19. India POCT Market - Analysts Recommendations
Disclaimer
Contact Us

License Rights:
Excel Only: USD 2000
Single User: USD 2500
Hard Copy: USD 3100
Single and Excel: USD 3500
Enterprise Wide: USD 5000
Slides: 152
Related Reports:
India Home Healthcare Market Outlook To 2023 - By Patient Profile (Elderly
Care, Physiotherapy, Stroke Rehabilitation, Wound Care And Others); By
Organized (Subscription And Non Recurring Model) And Unorganized, By
Major Cities
India Diagnostic Laboratories Market Outlook To 2021 Growing Prevalence Of
Diseases And Launch Of Technologically Advanced Procedures To Drive
Growth
Europe POCT Devices Market Outlook To 2022 - By Geography (Western
Europe & Eastern Europe), By Product (Blood Glucose POCT, Infectious POCT,
Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT,
Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT,
Fecal Occult POCT, Hb1ac POCT & Drugs Of Abuse POCT), By Customer
Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units And
Homecare & Patients)
5
Figure 1.1: India POCT Market Size on the basis of Revenue in INR Crore
and Growth Rate in Percentage (%), FY’2013- FY’2018 and FY’2023E
1.1 Executive Summary (1/3)
1
2
3
4
5
Growing Stage
CAGR (FY’2018-FY’2023E) : ~%
Moderately Concentrated
CAGR (FY’2013-FY’2018) : ~%
0.0
1,000.0
2,000.0
3,000.0
4,000.0
5,000.0
FY' 2013 FY' 2018 FY' 2023E
INRCrore
Source: Company Website, Ken Research Analysis
Cost, Expertise, Brand, Ease of
Use and Key Products Offered

© This is a licensed product of Ken Research and should not be copied
1.2. Executive Summary – Current Scenario
Figure 1.1: Flowchart for India POCT Market, FY2018
6
India POCT Market
INR ~ Crores
By Major Devices
INR ~ Crores
By End Users
INR ~ Crores
Blood Glucose
Testing Kits
INR ~ Crores
Blood Gas
Electrolytes
INR ~ Crores
Hospitals & Clinics INR
~ Crores
Diagnostic Labs
INR ~ Crores
Consumer/Individuals
INR ~ CroresInfectious Disease
Testing Kits
INR ~ Crores
Home Healthcare INR ~
Crores
Pregnancy And
Fertility Testing Kits
INR ~ Crores
Anticoagulant
Management
INR ~ Crores
Others
INR ~ Crores
Cardio
metabolic
Monitoring
INR ~ Crores
By Consumables &
Instruments
INR ~ Crores
Consumables
INR ~ Crores
Instruments
INR ~ Crores
Cholesterol
Testing Kits
INR ~Crores
Others
INR ~ Crores
Key Takeaways:
 The India POCT Market is currently at its
growing stage where new companies are setting
up their units in the country.
 The India POCT market has witnessed an
increased amount of investment and M&A
activities.
 Since India is an emerging market for POCT
device manufacturers, the lack of central
laboratories drives the growth for these devices.
Along with this, India constitutes of large rural
communities and hence the incidences for
infectious diseases are more.
 The elderly population in India have been
increasing and hence there can be seen a need
for handy rapid diagnosing devices which
ensure faster treatment and a reduced number
of hospital visits.
CAGR
FY2013-FY2018
~%
Market
Structure:
Moderately
Concentrated
CAGR for Elderly
Population ( FY2012-
FY2017):
~%

1.3. Executive Summary - Future Projections
Figure 1.2: Flowchart for Future Projection of India POCT Market, FY2018- FY2023E
7
India POCT Market
INR ~ Crores
By Major Devices
INR ~ Crores
By End Users
INR ~ Crores
Blood Glucose
Testing Kits
INR ~ Crores
Blood Gas
Electrolytes
INR ~Crores
Hospitals & Clinics
INR ~ Crores
Diagnostic Labs
INR ~ Crores
Consumer/Individuals
INR ~ CroresInfectious Disease
Testing Kits
INR ~ Crores
Home Healthcare
INR ~ Crores
Pregnancy And
INR ~ Crores
Anticoagulant
Management
INR ~ Crores
Others
INR ~ Crores
Cardio
metabolic
Monitoring
INR ~Crores
By Consumables &
Instruments
INR ~ Crores
Consumables
INR ~ Crores
Instruments
INR ~ Crores
Cholesterol
Testing Kits
INR ~Crores
Others
INR ~ Crores
Key Takeaways:
 The India POCT market is expected to grow at
an enormous rate owing to factors such as
compactness, portability and its usage by the
non laboratory personnel in the purview of
getting faster results.
 The major players operating in the market
include Abbott's India, Roche Diagnostics, J
Mitra & Co. Transasia Bio Medical, Bio Rad
Laboratories, Siemens Healthcare Private
Limited, Radiometer India and others.
 Launch of various new products in different
product genre is anticipated to expand the
target audience. Increasing internet
penetration & higher number of smart phones
users are likely to boost online sales in the
country.
 The growth in the POCT market is likely to be
driven by more product acceptance by retail
customers along with increased reliability and
trust in the POCT devices by hospitals and as
well as individuals.
CAGR
FY2018-FY2023E
~%
CAGR
FY2017-FY2022E
~%

6. India POCT Market Size- Current and Future Scenario

© This is a licensed product of Ken Research and should not be copied 9
6.1. By Historical Revenue, FY’2013- FY’2018
Figure 6.1: India POCT Market Size on the basis of Revenue in INR Crore and
Growth Rate in Percentage (%), FY’2013- FY’2018
8.4%
8.6%
8.8%
9.0%
9.2%
9.4%
9.6%
9.8%
10.0%
10.2%
0.0
500.0
1,000.0
1,500.0
2,000.0
2,500.0
3,000.0
FY'2013 FY'2014 FY'2015 FY'2016 FY'2017 FY'2018
Percentage(%)
INRCrore
INR Crore Growth Rate (%)
Key Takeaways:
 Increase in the Prevalence of Chronic Diseases: There has been an increase in the
number of Acute Diseases amongst the Indian population in the recent years.
Alongside this the prevalence of Chronic Illness such as Cancer has also been on a
rise lately. The estimated cases of Cancer for the FY’2016 stood at ~ which grew to
being ~ in the FY’2018. Increases of these diseases at such a large scale has pushed
the use of POCT devices in India. One of the growth drivers for the POCT market
also includes the elderly population in India which stood at ~ Millions in the
FY’2018. The age specific chronic diseases such as Diabetes Mellitus has driven the
sale of blood glucose testing kits.
 The study, which provides the first-of-its-kind nationally representative estimates of
cardiovascular mortality in India, shows that heart ailments caused more than 2.1
million deaths in India in 2015 at all ages, or more than a quarter of all deaths. At
ages 30-69 years, of 1.3 million cardiovascular deaths, 0.9 million (68.4%) were
caused by coronary heart disease and 0.4 million (28.0%) by stroke.
 Advancement in Medical Knowledge and R&D: With major manufacturers noticing
increase in per capita spending on healthcare by individuals, developing new and
handy POCT methods/devices has been on rise. Mergers & Acquisitions, acquiring
patents and high competition for market dominance has been prevalent.
 Unease Associated with Laboratory Testing Methods: Easy & convenient managing
of obesity and cardiovascular related diseases & fertility related issues, POCT
devices have become a way out for people to get faster and cheaper detection
method in comparison to cumbersome laboratory diagnostics. Pathology related
diagnostics test have been performed at home with ease moreover, diagnostic lab
test have become POCT-friendly, providing results within minutes. This has
encouraged households to opt for these devices for early detection hence, early
treatment.
 New companies venturing the market: With vast scope of innovation and
expansion, many new companies have been expanding their product lines into
POCT device manufacturing. Witnessing highly profitable business associated with
a successful new technology in POCT market, attracts new players.
Overall Market
Stage:
~
CAGR
~% During
FY’2013- FY’2018
Total Number of Patients Suffering from
stroke amount to ~ million in 2018 out
of which (~%) were in the age range of
18-45 years

6.2. By Forecasted Revenue, FY’2018- FY’2023E
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
14.0%
0.0
500.0
1,000.0
1,500.0
2,000.0
2,500.0
3,000.0
3,500.0
4,000.0
4,500.0
5,000.0
FY'2018 FY'2019 FY'2020 FY'2021 FY'2022 FY'2023
Percentage(%)
INRCrore
INR Crore Growth Rate (%)
Figure 6.2: India POCT Market Future Outlook and Projection on the basis of
Revenue in INR Crore and Growth Rate in Percentage (%), FY’2018- FY’2023 Key Takeaways:
 The India POCT market is expected to grow at an enormous rate owing to
factors such as compactness, portability and its usage by the non laboratory
personnel in the purview of getting faster results.
 India has been a country with one of the highest number of Diabetic
patients in the world and as per the International Federation of
Diabetes, the numbers are likely to increase to ~ Million by 2025. Such
alarming numbers have enabled the people to become proactive and keep a
check on their Glucose levels, not just for treatment purposes but also as a
preventive measure.
 The elderly population in India is one of target end users for the home
healthcare companies and overall POCT market in general. Increase in
incidence of diseases such as HIV, Infectious and Cardiac will lead to strong
growth of Infectious and Blood Glucose POCT devices.
 Growth in POCT market in the country is most likely to be influenced by
increase in the number of new entrants in the market, larger product
acceptance by retail customers, increase in reliability & trust in POCT devices
by home users & hospitals, expanding distribution channels and higher
marketing expenditure by the companies.
 Launch of various new products in different product genre is anticipated to
expand the target audience. Increasing internet penetration & higher
number of smart phones users are likely to boost online sales in the country.
 Upcoming fields: Ocular Point-of-care, Traumatic Brain Injury (focused on
developing POC for concussion management to assess the extent of brain
damage following trauma), Rare Diseases (One example is a rapid POC
device for sickle cell disease from Medomics), Neuropsychiatry Disorders
detection (such as Alzheimer‘s, Schizophrenia), Molecular Diagnostics and
Oncology (chemotherapy for disease progression using POC tests)
Future Projection of
Market Stage:
~
CAGR
~% During
FY’2018- FY’2023E
Projected Elderly
Population in
India, FY’2023:
~ Million

7. India POCT Market Segmentation- Current and Future scenario
By Major Devices
By End Users
By Consumables and Instruments
By Distribution Channel
By Region

Table 7.1: India POCT Market Segmentation by Major Devices on the basis of Revenue (In INR
Crore), FY’2018-FY’2023E
7.1. By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes,
Pregnancy and Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol
Testing Kits and Others), FY’2018- FY’2023E
POCT Device Market
Basis Major Devices
FY'2018E FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Blood Glucose Testing
Kits
~ ~ ~ ~ ~ ~
Infectious Disease
Testing Kits
~ ~ ~ ~ ~ ~
Blood Gas Electrolytes ~ ~ ~ ~ ~ ~
Pregnancy And
~ ~ ~ ~ ~ ~
Cardio metabolic
Monitoring
~ ~ ~ ~ ~ ~
Anticoagulant
Management
~ ~ ~ ~ ~ ~
Cholesterol Testing
Kits
~ ~ ~ ~ ~ ~
Others ~ ~ ~ ~ ~ ~
Total ~ ~ ~ ~ ~ ~
Figure 7.1: India POCT Market Segmentation by Major Devices on the
basis of Revenue (In Percentages), FY’2018-FY’2023E
CAGR (FY2018-
FY2023E) : ~% for
Blood Glucose
Testing
The number of patients with
diabetes mellitus is
expected to reach ~ million
in India and ~ million in
China compared to ~million
in U.S. by 2030.

7.1.1. Blood Glucose Testing Kits (1/2)
Table 7.2: Blood Glucose POCT Devices Market Segment Including Product Overview, Test Purpose, Instrument & Consumable, Market Size, Market Future, Major
Companies, Major Brands and Key Weakness
Parameters Description
Product Overview
• ~
Test Purpose • ~
Instrument &
Consumable
• ~
Market Size &
Related Numbers
• ~
Market Future • ~
Major Companies •~
Major Brands •~
Key Weakness
• ~

7.1.1. Blood Glucose Testing Kits (2/2)
Key Strengths
• Turn Around Time: Refers to the total
period from a clinician’s issuance and
delivery of
order, collection, transportation and
analysis of specimen and
calculation, verification and delivery of
results to review of results. A undisputed
advantage of POCT for BG is the rapid
turn-around time compared to CLT. POCT
gives results in ~ minutes while in CLT, it
takes ~ minutes.
• Patient Sample Volume: POCT devices
utilize very small volume of blood, ~ µL, in
contrast to CLT requiring ~ mL of blood.
For blood conservation in patients, it is
advisable to use POCT Devices as the
mean volume of blood loss per patient
per admission due to POCT for BG is only
~ ml however in CLT blood loss per patient
per admission due to phlebotomy is
between ~ and ~ mL (ICU: Between 600-
700 mL).
• Common Issues with CLT: Mislabeling
patient sample, Lost
sample, Contamination of
sample, Degradation of sample due to
delay in either transport or processing of
sample after arrival at the laboratory and
others.
 In the India POCT
market, Blood Glucose
Testing kits had the highest
share of ~% for the FY2018.
This testing kit is a device
used on a routine basis to
monitor glucose levels for
people at home or for
patients under tight
glycemic control
requirements.
KEY FACTS
 Type II Diabetes is ~ to ~
times more prevalent in
urban areas as compared to
the rural areas due to
factors such as
obesity, insulin resistance
and lifestyle changes owing
to urbanization.
 This high share owes to the
fact that number of people
suffering from Diabetes
Mellitus have increased from
being ~ Million in the year
2013 to ~ Million in the year
2017. Hence more number of
people are opting for such
monitoring devices.

7.1.2. Infectious Disease Testing Kits
Table 7.3: Infectious POCT Devices Market Segment Including Product Overview, Instrument & Consumable, Major Players, Market Size, Market Future, Major
Brands, Growth Strategies and Technologies
Product Overview
• ~
Instrument &
Consumer-able
• ~
Major Players • ~
Market Size &
Numbers
• ~
Market Future
• ~
Major Brands • ~
Company Growth
Strategies
• ~
Technologies • ~

7.1.3. Blood Gas Electrolytes
Table 7.4: Blood Gas Electrolytes Market Segment Including Product Overview, Instrument & Consumable, Replacement Time, Market Size, Market Future
and Major Players
Product
Overview
• ~
Instrument
&
Consumable
• ~
Replacement
Time
• ~
Market Size • ~
Market
Future
• ~
Major
Players
• ~

7.1.4. Pregnancy and Fertility Testing Kits
Table 7.5: Pregnancy And Fertility Testing Kits Market Segment Including Segment Overview, Product Details and Instrument & Consumer-able, Major Players, Major
Products, Product related difficulties faced by the consumers, Market Size and Market Future
Segment
Overview
• ~
Product Details
and Instrument
& Consumer-able
• ~
Major Players • ~
Major Products • ~
Market Size &
Related Numbers
• ~
Market Future • ~
Product related
difficulties faced
by the
consumers
• ~

7.1.5. Cardio metabolic Monitoring
Table 7.6: Cardio metabolic Monitoring POCT Devices Market Segment Including Product Overview, Instrument & Consumable, Current Market Trends, Major
Players, Market Size, End Users, Major Customers and Future Market Size
Product
Overview
• ~
Current Trends • ~
Instrument &
Consumable
• ~
Market Size &
Related
Numbers
• ~
Market Future
• ~
Major Customers • ~
Major Players • ~
Key End-user
Groups
• ~

7.1.6. Anticoagulant Management
Table 7.7: Anticoagulant Management POCT Devices Market Segment Including Segment Overview, Key Strengths, Major Players, Major Products, End Users, Market Size &
Related Numbers and Market Future
Segment
Overview
• ~
Strengths
• ~
End Users
• ~
Market Size &
Related Numbers
• ~
Market Future
• ~
Major Players • ~
Major Products • ~

7.1.7. Cholesterol Testing Kits
Table 7.8: Cholesterol Testing Kits Market Segment Including Product Overview, Instruments and consumables, Major Players, Leading Product, Market Size & Related
Numbers and Market Future
Product
Overview
• ~
Instrument &
Consumable
• ~
Market Size &
Related
Numbers
• ~
Market Future • ~
Major Players • ~
Cholesterol Testing Kits: ~%
CAGR

7.1.8. Others
Table 7.9: Other Products Market Segmentation Including HbA1c, Drug of Abuse Testing Kits, Urinalysis Testing Kits and Fecal Occult Testing Kits.
HbA1c
• ~
Drug of
Abuse
Testing Kits
• ~
Urinalysis
Testing Kits
• ~
Fecal Occult
Testing Kits
• ~

Table 7.10: India POCT Market Segmentation by End Users on the Basis of Revenue (in
INR Crore), FY’2018-FY’2023E
7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home
Healthcare and Others), FY’2018- FY’2023E (1/2)
POCT Device Market Basis
End Users
FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Hospitals & Clinics ~ ~ ~ ~ ~ ~
Consumer/Individuals ~ ~ ~ ~ ~ ~
Diagnostic Labs ~ ~ ~ ~ ~ ~
Home Healthcare ~ ~ ~ ~ ~ ~
Others ~ ~ ~ ~ ~ ~
Total ~ ~ ~ ~ ~ ~
Figure 7.2: India POCT Market Segmentation by End Users on the basis of
Revenue (in Percentages), FY’2018-FY’2023E
Parameter
Customers and Individuals
(B2C)
Diagnostics Labs & Primary
Care Units (B2B)
Hospitals & Clinics (B2B)
Key Users ~ ~ ~
Revenue Generated
(INR Million), FY’18
~ ~ ~
POCT Devices Used ~ ~ ~
Purpose of Devices ~ ~ ~
Usual Tests Done For ~ ~ ~
Technology Used ~ ~ ~
Table 7.11: Cross Comparison of POCT Devices on the Basis of End Users Including Key
Users, Revenue Generated & Others

7.2. By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs,
Home Healthcare and Others), FY’2018- FY’2023E (2/2)
Hospitals
and Clinics
The hospitals and clinics are expected to grow at a CAGR of 11.0% for the period of FY2018- FY2023E and are expected
to generate a revenue of INR 3600.0 Million from the POCT segment. The number of primary health centers operating in
India as of FY2018 stands at 25,743 and the ones operating as per the IPHS norms are 3,052. These numbers are not
sufficient to cater the increasing Indian population which is expected to be 1,365,302 for FY2023 and simultaneously the
number of patients have also been on a rise. This serves as a growth driver for all the hospitals and clinics providing POCT
solutions.
Consumers
and
Individuals
The segment for consumers and individuals is expected to grow at a CAGR of 12.6% for the period of FY2018- FY2023E
and is expected to generate a revenue of INR 4,477.7 Million for the FY2023. The growth drivers for the same includes the
lifestyle changes inculcated by the individuals as they have become more proactive in nature. Individuals have been using
POCT devices such as Cholesterol testing as a precautionary measure in order to prevent various cardiac diseases.
Individuals are also considering genetic disorders and are using POCT devices as a move in the process of becoming health
conscious.
Diagnostic
Labs
The diagnostic laboratories are expected to grow at a CAGR of 7.0% for the period of FY2018- FY2023E and the revenue
generated by them form the POCT segment is valued at INR 1053.6 Million. There has been a significant increase in the
number of people suffering from cancer in India wherein the number stood at 1,451,417 in the FY2016 and grew to
1,586,571 in the FY2018. The treatment for cancer requires certain tests which have to be conducted and those are
facilitated by these diagnostic labs. A total of 95 (approx.) NABL accredited diagnostic labs are prevailing in India.
Home
Healthcare
The Home Healthcare segment is expected to grow at a CAGR of 18.5% for the period of FY2018- FY2023E and are expected
to generate a revenue of INR 1,053.6 Million for the FY2023. This growth has been one of the highest amongst all the
considered segments due to various growth drivers which include the need for elderly care, Stroke patients, post ICU
care, post surgery care, mother and child care. The home healthcare market in India is dominated by the unorganized sector
contributing INR 17,004.8 Crores, with an overall share evaluated at 80% of the total market size. It can be seen as an
emerging segment as its still in its early growth stage and major players are still working on establishing their presence in
major cities.

Table 7.12: India POCT Market Segmentation by Consumables and
Instruments on the basis of Revenue for the Period of FY2018- FY2023 (in
INR Crore), FY’2018-FY’2023E
7.3. By Consumables and Instruments, FY’2018-FY’2023E (1/2)
Consuma
bles and
Instrumen
ts
FY'2018 FY'2019E FY'2020E FY'2021E FY'2022E FY'2023E
Consumab
les
(cartridge
s, test
strips etc.)
~ ~ ~ ~ ~ ~
Instrumen
ts (Main
Device)
~ ~ ~ ~ ~ ~
Total ~ ~ ~ ~ ~ ~
Figure 7.3: India POCT Market Segmentation by Consumables and
Instruments on the basis of Revenue in Percentage (%), FY2018- FY2023E
Parameter Instruments Consumables
Definition ~ ~
Rationale
and Average
Replacement
Rate
~ ~
Components
included
~ ~
Highest
Product
Category
Usage
~ ~
Table 7.13: Cross comparison on the Basis of Consumables and Instruments including
Definition, Rationale and Average Replacement Rate, Components included, Highest Product
Category Usage

7.3. By Consumables and Instruments, FY’2018-FY’2023E (2/2)
Company
Product
(Best Seller)
Diagnosed Product Category Instrument & Consumable Used
Alere ~ ~
~
~
Alere ~ ~ ~
Abott ~ ~
~
~
Alere ~ ~
~
~
Roche ~ ~
~
~
Roche ~ ~ ~
Roche ~ ~
~
~
Table 7.14: List of POCT products manufactured by Alere, Abbott Ltd. And Roche Diagnostics Limited Including Company, Best Seller Product, Diagnosed Product Category
and Instrument and Consumables Used

Table 7.15: India POCT Market Segmentation by Distribution Channel on
the Basis of Revenue in INR Million, FY’2018
7.4. By Distribution Channel (Distributors and Direct Sales), FY’2018
Distribution Channel FY' 2018
Through Distributors to end users
~
Through Distributors to retailers
Directly ~
Key Takeaways:
 Distributors: They play a key role in the overall POCT market in India constituting ~% of
market share on the basis of revenue as of FY2018. The share of distributors include the
distributors for end users and for retailers as well. The end users include the hospitals and
clinics, diagnostic labs, individuals and home healthcare companies. These users conduct
the POCT business on a large scale and in order to cater to such big clients, the POCT
companies prefer to sell their devices through distributors. Alongside catering to these end
users, POCT companies sell their devices through distributors to retailers such as small scale
pharmacies. There were ~ pharmacies in India as of FY2018.
 Margin of the distributors: The distributor’s margin on the sale of consumables is valued at
around ~% to ~% and the margin on the sale of instruments is valued at ~% to ~%.
 Major Distributors: The major distributors in the India POCT market include BHR
Diagnostics Pvt. Ltd.,
 Direct Sale: The direct sale of POCT devices constitute only ~% of the market share on the
basis of revenue in FY2018. Majority of the POCT companies do not contact their clients
directly and rather prefer using a medium to sell their products due to the high cost
involved. It has also been observed that the companies might face difficulties while entering
to new markets if they use direct sales over distributors. This corresponds to the fact that
the major companies providing POCT devices in India have their origins in different other
countries and in order to cater to the Indian market they choose to sell through distributors.
~ in 2014 ~ in 2016 ~ in 2018 Number of
Pharmacies
Figure 7.4: India POCT Market Segmentation by Distribution Channel
on the basis of Revenue in Percentage, FY’2018

7.5. By Region (Tier 1, Tier 2 and Tier 3 Cities), FY’2018 and FY’2023E
Figure 7.5: Market Segmentation and Future Projection by Region on the
basis of Sales of POCT Devices in Tier 1, Tier 2 and Tier 3 Cities of India in
Percentage (%), FY2018 and FY’2023E
Key Takeaways:
 The segmentation of the India POCT market by regions is based on the tier 1, tier 2 and tier 3
cities of India. Tier 1 city includes the metro cities of the country including
Delhi/NCR, Mumbai, Hyderabad, Bangalore, Chennai, and Kolkata.
 The sale of POCT devices is the highest in Tier 1 cities followed by tier 2 cities owing to the
factor that the country’s major Multi Specialty and Single Specialty hospitals are located in
these cities and people from all over India visit them for accessing specialized treatment.
 The people residing in tier 1 and tier 2 cities have a higher personal disposable income as
compared to other cities. Furthermore, the people in tier 1 cities are more aware about such
devices and have an easy access to them.
 The sales of POCT devices is the highest in Delhi followed by Chennai as these are the hub for
medical care patients. The country’s topmost Multi Specialty and Super Specialty Hospitals are
located in these cities including Apollo Specialty Hospital in Chennai and All India Institute of
Medical Sciences (AIIMS) in Delhi. POCT devices for diseases such as Cardiac diseases, stroke
and diabetes are not only used by these hospitals but also by the patients visiting these
hospitals for varied treatments in order to conduct regular self checkups.
 It has also been observed that the incidence of diseases such as Cardiac
diseases, Diabetes, high Cholesterol and stroke are more in the urban areas of India owing to
the lifestyle changes. Perhaps, this has encouraged the sales of POCT devices as people have
started using POCT devices for regular self check-ups as well.
 Furthermore, it has been anticipated that the sale of POCT devices would reduce in Tier 1 cities
and in turn the sales would increase in the Tier 3 cities. The reasons behind this paradigm shift
could possibly include the increasing awareness and government initiatives for improving the
rural healthcare in Tier 3 cities. For instance, one of the government’s program named as
‘Ayushman Bharat’ for rural healthcare betterment could seek more traction in the near future.
 The private companies entering the India POCT market have already started setting up their
manufacturing units in Tier 2 and Tier 3 cities of India. For instance, companies such as Becton
Dickinson India, Boston Scientiic Corp and others have set up their manufacturing units in
various areas of Haryana and Chandigarh.
City Market Share of Tier-1 cities (in %), FY2018
Delhi/NCR ~
Chennai ~
Mumbai ~
Bangalore ~
Hyderabad ~
Kolkata ~
Total ~
Table 7.16: Market Share (Estimated) of Each City under Tier 1 in
Percentage (%), FY’2018

15. Competition Landscape of India POCT Market

29
Cost
Expertise
Brand
15.1. Competitive Scenario (Competing Parameters, Major Players and Competition Structure)
Ease of Use
Market Stage
Competitive
Structure
Key Metrics of India POCT Market
~
~%
~
Number of
Companies operating
~
CAGR 2013-2018

Table 15.1: Market Share of Major Players Operating in the India POCT Market on
the Basis of Revenue in Percentage (%), FY’2018
15.2. Market Share of Major Players - By Revenue, FY’2018
Major Players Revenue Share (in %), FY’2018
Abbott's India/ Alere India ~
Roche Diagnostics ~
Danaher Corporation ~
J Mitra & Co. ~
Transasia Bio Medical ~
Bio Rad Laboratories ~
Siemens Healthcare Private Limited
~
Beckman Coulter India Pvt Ltd
~
Diasys India ~
Others ~
Key Takeaways:
 The key players in the India POCT market include Abbott India
Limited, Roche Diagnostics Limited, Siemens
Healthineers, Johnson & Johnson, J Mitra & Co. Pvt. Ltd. and
companies under Danaher Corporation operating in India.
 Taking into consideration the diversity of the POCT products
offered in this segment, there is no clear industry leader.
However, companies specialize in some particular sub
segments.
 The total number of companies operating in the market
exceed ~ in numbers. Although more than half of he market is
covered by the major players existing in the market.
 There are more number of international players dominating
the India POCT market including companies such as
Abbott, Danaher Corporation, Beckman Coulter and others.
Companies have started setting up their manufacturing units in
India as well.
 The market share of other companies constitute a large
amount of 28.0% to 43.0% for the FY2018 as the market
structure of the industry is moderately concentrated.
 Other companies include Hemocue, Atomo
Diagnostics, Renesas Electronics , Avalun , Wersen ,S D
Biocenter, Trivitron Healthcare Pvt Ltd, Becton Dickinson India
Pvt Ltd and others.

17. Company Profiles of Major Players in India POCT Market
Abbott India Limited
Roche Diagnostics
Siemens Healthcare Pvt. Ltd.
Beckman Coulter India Pvt. Ltd.
J Mitra & Co. Pvt Ltd.
Trans Asia Biomedical
Radiometer India
Bio Rad Labratories
DiaSys India
Others

Table 17.1: Company profile of Abbott India Limited including Company Overview, Business Model, Strengths, Market Share, Key POCT Devices Offered and Mergers &
Acquisitions
17.1. Abbott India Limited (1/3)
Company Overview • ~
Business Model • ~
Strengths
• ~
Market Share
• ~
Key POCT Devices
Offered
• ~

0.00
10,000.00
20,000.00
30,000.00
40,000.00
FY'2015 FY'2016 FY'2017
INRMillion
Parameters FY’15 FY’16 FY’17
Revenue from Operations ~ ~ ~
Other Income ~ ~ ~
Total Income ~ ~ ~
Total Expenses ~ ~ ~
EBITA ~ ~ ~
PAT ~ ~ ~
Figure 17.1: Total Income of Abbott India Limited from All its
Brands, FY’2015 - FY’2017
Table 17.2: Financials of Abbott India Limited (in INR Million), FY2015, FY2016
and FY2017
• ~
Mergers and
Acquisitions
• ~
Table 17.1: Company profile of Abbott India Limited including Company Overview, Business Model, Strengths, Market Share, Key POCT Devices Offered and Mergers
& Acquisitions

Parameters FreeStyle Lite
FreeStyle
Freedom Lite
FreeStyle
InsuLinx
FreeStyle
Precision Neo
Description • ~ • ~ • ~ • ~
Sample Size • ~ • ~ • ~ • ~
Fast Test Time • ~ • ~ • ~ • ~
Display • ~ • ~ • ~ • ~
Meter Size • ~ • ~ • ~ • ~
Alarms • ~ • ~ • ~ • ~
Ability to Reapply Blood • ~ • ~ • ~ • ~
Test Strip Port Light • ~ • ~ • ~ • ~
Backlight • ~ • ~ • ~ • ~
Alternate Site Testing • ~ • ~ • ~ • ~
Battery Life • ~ • ~ • ~ • ~
Meter Memory • ~ • ~ • ~ • ~
Table 17.3: Product Portfolio of Blood Glucose Monitoring Systems of Abbott India Limited

The research reports provided by Ken Research are for the personal information of the authorized recipient and is not for public distribution and should not be
reproduced or redistributed without prior permission. None of this material may be used for any commercial or public use until unless authorized by Ken
Research. The report will only be used as per the license rights authorized by Ken Research.
The information provided in the research documents is from publicly available data and other sources, which are reliable. Efforts are made to try and ensure
accuracy of data. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the
warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness
of any information, apparatus, product, or process disclosed, or represents that its use will not infringe privately owned rights.
The report also includes analysis and views expressed by our research team. The research reports are purely for information purposes. The opinions expressed
are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Investors should not solely
rely on the information contained in the research documents and must make investment decisions based on their own investment objectives, risk profile and
financial position. The recipients of this material should take their own professional advice before acting on this information.
Ken Research will not accept returns of reports once dispatched due to the confidentiality of information provided in our reports. In case, a report qualify for
return, we will issue a credit, minus shipping charges, of equal value to the original purchase price, toward a future purchase—no refunds. The decision about
whether the product return can be accepted or not is solely at our discretion. Any dispute will be subject to laws of India and exclusive jurisdiction of Indian
Courts.
No part of this manual or any material appearing may be reproduced, stored in or transmitted in any other format without written permission of Ken
Research. This is purely for the reference of the concerned entity.
35
Disclaimer

36
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, Sector 49, Gurgaon, Haryana - 122001
Office: +91 9311149880
Web: www.kenresearch.com
Email: namit@kenresearch.com
Contact Us
CONTACT US

India poct market outlook to 2023

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to India poct market outlook to 2023

Similar to India poct market outlook to 2023 (20)

More from Ashish Chauhan

More from Ashish Chauhan (15)

Recently uploaded

Recently uploaded (20)

India poct market outlook to 2023